halofuginone has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, Y; Hang, B; Hu, J; Lei, L; Sun, Y; Wang, L; Wang, X; Xia, X; Xu, Y; Zhang, S; Zheng, Y | 1 |
1 other study(ies) available for halofuginone and cyclin d1
Article | Year |
---|---|
miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Exosomes; Female; Histone Deacetylase 2; Humans; MCF-7 Cells; Medicine, Chinese Traditional; MicroRNAs; Piperidines; Quinazolinones | 2019 |